about
Plakoglobin: role in tumorigenesis and metastasisDesmosome regulation and signaling in diseaseDesmosomes in acquired diseaseLoss of Grainy head-like 1 is associated with disruption of the epidermal barrier and squamous cell carcinoma of the skinFocal Adhesion Kinase-Dependent Role of the Soluble Form of Neurotensin Receptor-3/Sortilin in Colorectal Cancer Cell DissociationMechanistic basis of desmosome-targeted diseasesKeratins control intercellular adhesion involving PKC-α-mediated desmoplakin phosphorylation.Down-regulated γ-catenin expression is associated with tumor aggressiveness in esophageal cancer.Regulation of Desmocollin3 Expression by Promoter Hypermethylation is Associated with Advanced Esophageal Adenocarcinomas.Galectin-3 regulates desmoglein-2 and intestinal epithelial intercellular adhesion.Mechanisms of Autoantibody-Induced Pathology.Implications of PPPDE1 expression in the distribution of plakoglobin and β-catenin in pancreatic ductal adenocarcinomaImpairement of HT29 Cancer Cells Cohesion by the Soluble Form of Neurotensin Receptor-3.Plakophilin-2 promotes tumor development by enhancing ligand-dependent and -independent epidermal growth factor receptor dimerization and activation.Desmosomes: regulators of cellular signaling and adhesion in epidermal health and disease.Folliculin, the product of the Birt-Hogg-Dube tumor suppressor gene, interacts with the adherens junction protein p0071 to regulate cell-cell adhesion.Structure, function, and regulation of desmosomes.Mutational and functional analysis of the tumor-suppressor PTPRD in human melanoma.Expression of DSG1 and DSC1 are prognostic markers in anal carcinoma patients.Inflammation-induced desmoglein-2 ectodomain shedding compromises the mucosal barrier.Classical and desmosomal cadherins at a glance.Mammary collective cell migration involves transient loss of epithelial features and individual cell migration within the epithelium.A functional module-based exploration between inflammation and cancer in esophagus.Mimicking normal tissue architecture and perturbation in cancer with engineered micro-epidermisDeficiency of the p53/p63 target Perp alters mammary gland homeostasis and promotes cancer.Holding Tight: Cell Junctions and Cancer Spread.Mechanisms that link the oncogenic epithelial-mesenchymal transition to suppression of anoikis.Desmoglein-1, differentiation, and disease.Tie2 Regulates Tumor Metastasis of Oral Squamous Cell Carcinomas.Transmembrane protein PERP is a component of tessellate junctions and of other junctional and non-junctional plasma membrane regions in diverse epithelial and epithelium-derived cells.Quantitative proteomics of extracellular vesicles derived from human primary and metastatic colorectal cancer cells.Laminin, gamma 2 (LAMC2): a promising new putative pancreatic cancer biomarker identified by proteomic analysis of pancreatic adenocarcinoma tissuesDirect RNA sequencing mediated identification of mRNA localized in protrusions of human MDA-MB-231 metastatic breast cancer cellskillerFLIP: a novel lytic peptide specifically inducing cancer cell death.Cell-cell connectivity: desmosomes and disease.The Eph/Ephrin family in cancer metastasis: communication at the service of invasion.Cell adhesion and its endocytic regulation in cell migration during neural development and cancer metastasis.Proteomics of extracellular vesicles: Exosomes and ectosomes.Beyond E-cadherin: roles of other cadherin superfamily members in cancer.Plakophilins in desmosomal adhesion and signaling.
P2860
Q21296710-27D60065-550B-41EA-8783-2905382CE90EQ27013675-70410CF4-4854-4E60-A5E9-52D2AD892213Q27025901-51B05D5B-4E82-4C7D-A5C8-C2C3B7CC78FAQ27321159-A7A4EC44-50D1-4785-A5D9-F89A05310E79Q28067118-BE9710C8-5F4E-4A59-871B-D9A3402DDBF4Q28295898-F61704DC-FA16-4224-92EC-9FD3D223AF9CQ30540086-3221E845-7AC7-41B9-97DF-D9C894FE45FBQ33626839-944F2718-B9E2-4C49-B57B-A0C128DB784FQ33634990-7EE65733-BDB1-4F9D-90EF-04B236BBBF8EQ33675740-40CA04B7-64F4-41D9-B6EC-BFA1FF0E67F5Q33740580-09E83031-396D-4D43-B44D-1D591470E47AQ33967704-9BB86B05-99EF-4E66-AD3F-3638AD975CD2Q34170538-C3C107E5-8E7E-4C5F-A704-3AF22ED1A432Q34297943-0EBC8B66-9BE8-47D9-8F99-4F519893F9A3Q34400278-49565BB1-2607-463E-92E0-105058AFBA26Q34471857-41063E26-19FD-42DE-895C-E8E9465BC8A5Q35107942-C2B5C40F-4A77-47D9-AA54-BA1DB4AE5893Q35382936-A3CA2603-4C5E-4A88-9248-18B9C98F5637Q35879804-D8EB7800-B58B-4CA0-83EF-1566267D20DAQ36058429-62B221C5-3541-4060-852E-56370CED0076Q36111253-CF37B644-20EC-4EB9-84A0-5A67FAD26CE6Q36111266-54885168-8436-465A-BE65-9043DB1E3558Q36188784-FD8D86E7-3CD8-408E-96B9-D742462984FFQ36222257-A78DEF4E-2747-43E8-890A-88653882AEEAQ36245627-F16CFA33-B180-497F-B191-D2F2AD24DD9EQ36638980-0127DAAF-166B-4ED4-B565-09E8A87AD248Q36702544-D2B0686D-3D36-4A2E-A3D1-19A7B9010FAEQ36733524-D36FDDB5-0182-4C04-BB69-677460ACC0B9Q36764938-40054302-5711-41D2-BA91-437B0459EBABQ36952057-7BA5E9DC-6681-4F18-8584-BBF361476910Q37141149-E836D799-E9B9-4838-8F66-EF7831AFA0E4Q37214680-79D3543B-8364-433B-8744-10BB4AC36824Q37351886-A4DF27A5-82B4-4AB1-A4AE-0F7FCF879890Q37577463-C38E54FA-B1A2-4D86-94FA-9EA32DC54AEFQ37944471-87B9EBF6-25AD-4A30-8924-FCC63BA3EA03Q38006838-CD03FB85-BB21-46CA-8F7F-A3BFDF702ABDQ38011157-732603D1-E336-4AD2-9FD8-838B6A030A30Q38178208-C41ADFD1-EA98-427F-9E51-D5CF082977A4Q38179961-374E49E6-82B8-4367-8EA5-04E5C0898B49Q38181535-E0E0FA4B-5633-4681-81BD-7BFDD500E944
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Desmosomes: new perpetrators in tumour suppression
@en
Desmosomes: new perpetrators in tumour suppression.
@nl
type
label
Desmosomes: new perpetrators in tumour suppression
@en
Desmosomes: new perpetrators in tumour suppression.
@nl
prefLabel
Desmosomes: new perpetrators in tumour suppression
@en
Desmosomes: new perpetrators in tumour suppression.
@nl
P2860
P356
P1476
Desmosomes: new perpetrators in tumour suppression
@en
P2093
Laura D Attardi
Rachel L Dusek
P2860
P2888
P304
P356
10.1038/NRC3051
P407
P577
2011-05-01T00:00:00Z
P6179
1004783151